NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

NWBO stock fell the day of 5/10 based on a number of factors,

1) Preplanned stock blitz to try to drive the price south.
2) Activation of planned blitz prior to the initial start of the presentation.
3) The presentation could have been more focused to illustrate the real OS results.
4) False information from certain individuals.
5) False information from cancer media based on a specific individual'
6) Management should have addressed these issues sooner.
There are other factors that should be on this list including some reserved based on ongoing investigations.

No doubt there are a number of individuals who do not want NWBO to succeed as they continue to post their biased information in the attempts to get investors to dump this stock. However, the fact of the matter is that NWBO product DCVax-L works. The OS data results prove this and there are multiple individuals with real testimonies that have been also revealed. In addition, there are multiple doctors, scientist and professionals are not only impressed but are excited that NWBO's products will in fact more forward. Once again, the advanced manufacturing capabilities "Flaskworks Devices (EDENS)" had received USPTO patent authorization in 03/22. The good news is that the presentation results instantiate support the fact that the OS data is valid. The Advent facility started to ramp up their advanced automation processes as defined, and the goal was to complete this task before the end of the year even with the supply chain issues. However, the supply chain issues were resolved ahead of schedule. In light of all the effort to bring the Advent facility up to speed, it appears this will occur before the end of the year. In all, many are forward to GMP approvals followed by MIA and MA approvals soon afterwards. Yes, progress takes time as NWBO continues to move forward.
IMPO.